As public awareness and demand for GLP-1 RAs continue to grow, particularly for off-label or non-covered use for weight loss, the volume of authorization requests strain existing resources
Shima Hadidchi, MD, Family Practice, can discuss the potential benefits, risks, and alternative options
The MHRA actively works to identify and remove illegal medicines from the UK market and regularly issues warnings about counterfeit weight-loss products
GSH deficiency results in the activation of von Willebrand Factor (Ibrahim et al., 2004) and in the accumulation of ROS, which affect clotting and platelet activation, impair endothelial function, and predispose to the risk of thrombotic events (Violi et al., 2017): notably, hypercoagulation is a prominent life-threatening complication in COVID-19 patients (Giardini et al., 2020)